• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ultragenyx Pharmaceu (NQ: RARE )

    45.08 -2.56 (-5.37%)
    Streaming Delayed Price Updated: 1:10 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Ultragenyx Pharmaceu

    < Previous 1 2 3 4 5 6 7 8 Next >
    The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... 
    Via Benzinga
    Exposures COVID-19
    Earnings Scheduled For November 2, 2021
    Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •... 
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
    Over the past 3 months, 4 analysts have published their opinion on Ultragenyx Pharmaceutical (NASDAQ: 
    Via Benzinga
    Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
    The FDA has removed the clinical hold on GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc's (NASDAQ: RARE) GTX-102 trial for... 
    Via Benzinga
    Exposures Product Safety
    Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
    Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
    Via Benzinga
    Exposures Product Safety
    The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
    Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
    Upgrades For Cabot Oil & Gas Corp (NYSE:COG),... 
    Via Benzinga
    Return on Capital Employed Insights for Ultragenyx Pharmaceutical
    After pulling data from Benzinga Pro it seems like during Q2, Ultragenyx Pharmaceutical (NASDAQ:RARE) posted sales of $86.97 million. Earnings were up 22.33%, but Ultragenyx... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021
    Upgrades According to DA Davidson, the prior rating for PaySign Inc (NASDAQ: 
    Via Benzinga
    Return on Capital Employed Overview: Ultragenyx Pharmaceutical
    After pulling data from Benzinga Pro it seems like during Q2, Ultragenyx Pharmaceutical (NASDAQ:RARE) posted sales of $86.97 million. Earnings were up 22.33%, but Ultragenyx... 
    Via Benzinga
    Ultragenyx Pharmaceutical inc (RARE) Q2 2021 Earnings Call Transcript
    RARE earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Ultragenyx Pharmaceutical: Q2 Earnings Insights
    Shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down... 
    Via Benzinga
    Ultragenyx Pharmaceuticals Analyst Turns Bullish: What Investors Need To Know
    A BofA Securities analyst is turning bullish on shares of Ultragenyx Pharmaceuticals (NASDAQ: 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2021
    Upgrades For Nutrien Ltd (NYSE: 
    Via Benzinga
    Earnings Scheduled For August 2, 2021
    Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is estimated to report earnings for its second quarter. • Addex Therapeutics (NASDAQ:ADXN) is... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) shares moved upwards by 42.0% to $17.85 during Tuesday's pre-market session. The company's market cap stands at $2.... 
    Via Benzinga
    GeneTx Bio-Ultragenyx's Angelman Syndrome Study To Start Enrollment In Canada
    GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) have received clearance from Health Canada to begin enrolling in the Phase 1/... 
    Via Benzinga
    CNS Pharmaceuticals Commences Patient Enrollment in Potentially Pivotal Study of Berubicin
    CNS Pharmaceuticals today announced open enrollment for its potentially pivotal study evaluating the efficacy and safety of Berubicin in the treatment of recurrent GBM. 
    Via Talk Markets
    Ultragenyx's Gene Therapies For Genetic Metabolic Disorders Show Longer-Term Durable Responses
    Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) has announced longer-term data from the Glycogen Storage Disease Type Ia (GSDIa) and Ornithine Transcarbamylase (... 
    Via Benzinga
    10 Biggest Price Target Changes For Thursday
    Rosenblatt lifted the price target on Qorvo Inc (NASDAQ: QRVO) from $175 to $200. Qorvo shares rose 0.8% to $184.01 in pre-market trading. Needham boosted HubSpot Inc (NASDAQ:... 
    Via Benzinga
    The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
    Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    Ultragenyx Pharmaceutical Inc (RARE) Q1 2021 Earnings Call Transcript
    RARE earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Earnings Scheduled For May 4, 2021
    Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.